Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4800
+0.0234 (5.12%)
At close: Feb 11, 2026, 4:00 PM EST
0.4785
-0.0015 (-0.31%)
After-hours: Feb 11, 2026, 4:43 PM EST
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $50.22 million as of February 11, 2026. Its market cap has increased by 143.87% in one year.
Market Cap
50.22M
Enterprise Value
70.64M
1-Year Change
143.87%
Ranking
Category
Stock Price
$0.48
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $50.22M, an increase of 45.59%. That is a compound annual growth rate of 30.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 47.77M | -9.58% |
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acrivon Therapeutics | 52.70M |
| Instil Bio | 52.63M |
| Radiopharm Theranostics | 52.18M |
| Q32 Bio | 52.17M |
| MiNK Therapeutics | 51.49M |
| Liminatus Pharma | 49.80M |
| CervoMed | 49.13M |
| OS Therapies | 47.89M |